After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...

Former OpenAI researcher Daniel Kokotajlo claims Google DeepMind's Demis Hassabis planned to be an "AGI dictator".

Google DeepMind won bragging rights that its competitors in the field of AI could only dream of. A share of the 2024 Nobel Prize in Chemistry was awarded to Demis Hassabis, its CEO, and John Jumper, ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

"Immerse yourself now in AI tools," said Google DeepMind Chief Executive Officer Demis Hassabis on the May 23 "Hard Fork" podcast. His warning to Gen Alpha came as generative AI writes code, mixes ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...

Sir Demis Hassabis said it feels like a recognition that AI is mature enough now to help with scientific discovery. Read more at straitstimes.com. Read more at straitstimes.com.

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Tech CEOs are promising increasingly outlandish visions of the 2030s, powered by "superintelligence", but the reality is that ...